Urinary Aquaporin 2 and Expression of the NPHS2 Gene in Adults Suffering From Nephrotic Syndrome

Plain-language summary

This study examines urinary aquaporin 2 levels and expression (activity) of the NPHS2 gene in adult patients with nephrotic syndrome. It enrolled male and female nephrotic syndrome patients over 18 whose diagnosis was confirmed by a kidney biopsy. The research was conducted as a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Regional Hospital Holstebro

Start date

5/1/2005

Countries

Denmark

Related genes

Locations

• Holstebro, Denmark

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

adult patients with nephrotic syndrome in the years 1995 until now; both male and female; the kidney disease must be based upon a kidney biopsy ; age \> 18 years -

Exclusion Criteria:

severe diseases in the heart, lungs or liver; diabetes mellitus; other not well-treated diseases in endocrine organs; cancer unwillingness to participate

\-